Truncated Form of the Epstein-Barr Virus Protein EBNA-LP Protects against Caspase-Dependent Apoptosis by Inhibiting Protein Phosphatase 2A | Zendy

Julie Garibal | Zendy; Émilie Hollville | Zendy; Andrew Bell | Zendy; Gemma L. Kelly | Zendy; Benjamin Renouf | Zendy; Yasushi Kawaguchi | Zendy; Alan B. Rickinson | Zendy; Joëlle Wiels | Zendy

Open Access

Truncated Form of the Epstein-Barr Virus Protein EBNA-LP Protects against Caspase-Dependent Apoptosis by Inhibiting Protein Phosphatase 2A

Author(s) -

Julie Garibal,

Émilie Hollville,

Andrew Bell,

Gemma L. Kelly,

Benjamin Renouf,

Yasushi Kawaguchi,

Alan B. Rickinson,

Joëlle Wiels

Publication year - 2007

Publication title -

journal of virology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.617

H-Index - 292

eISSN - 1070-6321

pISSN - 0022-538X

DOI - 10.1128/jvi.02435-06

Subject(s) - biology , transfection , microbiology and biotechnology , apoptosis , gene isoform , epstein–barr virus , protein phosphatase 2 , cytoplasm , virus , staurosporine , phosphatase , gene , virology , signal transduction , genetics , protein kinase c , phosphorylation

The Epstein-Barr virus (EBV)-encoded leader protein, EBNA-LP, strongly activates the EBNA2-mediated transcriptional activation of cellular and viral genes and is therefore important for EBV-induced B-cell transformation. However, a truncated form of EBNA-LP is produced in cells infected with variant EBV strains lacking EBNA2 due to a genetic deletion. The function of this truncated form is unknown. We show here that some Burkitt's lymphoma cells harboring defective EBV strains are specifically resistant to the caspase-dependent apoptosis induced by verotoxin 1 (VT-1) or staurosporine. These cells produced low-molecular-weight Y1Y2-truncated isoforms of EBNA-LP, which were partly localized in the cytoplasm. The transfection of sensitive cells with constructs encoding truncated EBNA-LP isoforms, but not full-length EBNA-LP, induced resistance to caspase-mediated apoptosis. Furthermore, VT-1 induced protein phosphatase 2A (PP2A) activation in sensitive cells but not in resistant cells, in which the truncated EBNA-LP interacted with this protein. Thus, the resistance to apoptosis observed in cells harboring defective EBV strains most probably results from the inactivation of PP2A via interactions with low-molecular-weight Y1Y2-truncated EBNA-LP isoforms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research